Dataset Information

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution.

ABSTRACT: Aging is the main risk factor for cardiovascular diseases. In humans, cardiac aging remains poorly characterized. Most studies are based on chronological age (CA) and disregard biological age (BA), the actual physiological age (result of the aging rate on the organ structure and function), thus yielding potentially imperfect outcomes. Deciphering the molecular basis of ventricular aging, especially by BA, could lead to major progresses in cardiac research. We aim to describe the transcriptome dynamics of the aging left ventricle (LV) in humans according to both CA and BA and characterize the contribution of microRNAs, key transcriptional regulators. BA is measured using two CA-associated transcriptional markers: CDKN2A expression, a cell senescence marker, and apparent age (AppAge), a highly complex transcriptional index. Bioinformatics analysis of 132 LV samples shows that CDKN2A expression and AppAge represent transcriptomic changes better than CA. Both BA markers are biologically validated in relation to an aging phenotype associated with heart dysfunction, the amount of cardiac fibrosis. BA-based analyses uncover depleted cardiac-specific processes, among other relevant functions, that are undetected by CA. Twenty BA-related microRNAs are identified, and two of them highly heart-enriched that are present in plasma. We describe a microRNA-gene regulatory network related to cardiac processes that are partially validated in vitro and in LV samples from living donors. We prove the higher sensitivity of BA over CA to explain transcriptomic changes in the aging myocardium and report novel molecular insights into human LV biological aging. Our results can find application in future therapeutic and biomarker research.

SUBMITTER: Ramos-Marques E

PROVIDER: S-EPMC8282276 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution.

Ramos-Marquès Estel E García-Mendívil Laura L Pérez-Zabalza María M Santander-Badules Hazel H Srinivasan Sabarathinam S Oliveros Juan Carlos JC Torres-Pérez Rafael R Cebollada Alberto A Vallejo-Gil José María JM Fresneda-Roldán Pedro Carlos PC Fañanás-Mastral Javier J Vázquez-Sancho Manuel M Matamala-Adell Marta M Sorribas-Berjón Juan Fernando JF Bellido-Morales Javier André JA Mancebón-Sierra Francisco Javier FJ Vaca-Núñez Alexánder Sebastián AS Ballester-Cuenca Carlos C Jiménez-Navarro Manuel M Villaescusa José Manuel JM Garrido-Huéscar Elisa E Segovia-Roldán Margarita M Oliván-Viguera Aida A Gómez-González Carlos C Muñiz Gorka G Diez Emiliano E Ordovás Laura L Pueyo Esther E

Aging cell 20210606 7

Aging is the main risk factor for cardiovascular diseases. In humans, cardiac aging remains poorly characterized. Most studies are based on chronological age (CA) and disregard biological age (BA), the actual physiological age (result of the aging rate on the organ structure and function), thus yielding potentially imperfect outcomes. Deciphering the molecular basis of ventricular aging, especially by BA, could lead to major progresses in cardiac research. We aim to describe the transcriptome dy ...[more]

PMID: 34092006

Similar Datasets

Project description:BackgroundHeart failure (HF) is associated with highly significant morbidity, mortality, and health care costs. Despite the significant advances in therapies and prevention, HF remains associated with poor clinical outcomes. Understanding the contractile force and kinetic changes at the level of cardiac muscle during end-stage HF in consideration of underlying etiology would be beneficial in developing targeted therapies that can help improve cardiac performance.ObjectiveInvestigate the impact of the primary etiology of HF (ischemic or non-ischemic) on left ventricular (LV) human myocardium force and kinetics of contraction and relaxation under near-physiological conditions.Methods and resultsContractile and kinetic parameters were assessed in LV intact trabeculae isolated from control non-failing (NF; n = 58) and end-stage failing ischemic (FI; n = 16) and non-ischemic (FNI; n = 38) human myocardium under baseline conditions, length-dependent activation, frequency-dependent activation, and response to the β-adrenergic stimulation. At baseline, there were no significant differences in contractile force between the three groups; however, kinetics were impaired in failing myocardium with significant slowing down of relaxation kinetics in FNI compared to NF myocardium. Length-dependent activation was preserved and virtually identical in all groups. Frequency-dependent activation was clearly seen in NF myocardium (positive force frequency relationship [FFR]), while significantly impaired in both FI and FNI myocardium (negative FFR). Likewise, β-adrenergic regulation of contraction was significantly impaired in both HF groups.ConclusionsEnd-stage failing myocardium exhibited impaired kinetics under baseline conditions as well as with the three contractile regulatory mechanisms. The pattern of these kinetic impairments in relation to NF myocardium was mainly impacted by etiology with a marked slowing down of kinetics in FNI myocardium. These findings suggest that not only force development, but also kinetics should be considered as a therapeutic target for improving cardiac performance and thus treatment of HF.

Dataset Information

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution.

Publications

Chronological and biological aging of the human left ventricular myocardium: Analysis of microRNAs contribution.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets